Synergistic effect of green tea catechins on cell growth and apoptosis induction in gastric carcinoma cells

Biological and Pharmaceutical Bulletin

Volumn 28, Issue 4, 2005, Pages 574-579

  Horie, Nobuyuki ^a   Hirabayashi, Naomi ^a   Takahashi, Yoshie ^a   Miyauchi, Yuko ^a   Taguchi, Hiroko ^a   Takeishi, Keiichi ^a  

^a UNIVERSITY OF SHIZUOKA   (Japan)

Author keywords

( ) epigallocatechin gallate (EGCG); Apoptosis; Gastric cancer; Growth inhibition; Synergistic effect

Indexed keywords

CASPASE; CATALASE; CATECHIN; EPIGALLOCATECHIN GALLATE; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENTIATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GROWTH INHIBITION; HUMAN; HUMAN CELL; STOMACH CARCINOMA; TEA; WESTERN BLOTTING;

APOPTOSIS; CASPASES; CATALASE; CATECHIN; CELL LINE, TUMOR; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; HUMANS; STOMACH NEOPLASMS; TEA;

EID: 21144458334     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.28.574     Document Type: Article

References (18)

1. Yang C. S., Maliakal P., Meng X., Annu. Rev. Pharmacol. Toxicol., 42, 25-54 (2002).
2. Yang G.-Y., Liao J., Kim K., Yurkow E. J., Yang C. S., Carcinogenesis, 19, 611-616 (1998).
3. Muramatsu K., Ogun I., Isemura M., Sugiyama K., Yamamoto-Maeda M., "Health Science of Tea," Japan Scientific Societies Press, Tokyo, 2002, pp. 52-64.
4. Roy M., Chakrabarty S., Sinha D., Bhattacharya R. K., Siddiqi M., Mutation Res., 523-524, 33-41 (2003).
5. Lambert J. D., Yang C. S., J. Nutr., 133, 3262S-3267S (2003).
6. Stennicke H. R., Salvesen G. S., Biochim. Biophys. Acta, 1477, 299-306 (2000).
7. Nagata S., Exp. Cell Res., 256, 12-18 (2000).
8. Ichijo H., Oncogene, 18, 6087-6093 (1999).
9. Saeki K., Kobayashi N., Inazawa Y., Zhang H., Nishitoh H., Ichijo H., Saeki K., Isemura M., You A., Biochem. J., 368, 705-720 (2002).
10. Hayakawa S., Saeki K., Sazuka M., Suzuki Y., Shoji Y., Ohta T., Kaji K., You A., Isemura M., Biochem. Biophys. Res. Commun., 285, 1102-1106 (2001).
11. Suganuma M., Okabe S., Kai Y., Sueoka N., Sueoka E., Fujiki H., Cancer Res., 59, 44-47 (1999).
12. Okabe S., Ochiai Y., Aida M., Park K., Kim S.-J., Nomura T., Suganuma M., Fujiki H., Jpn. J. Cancer Res., 90, 733-739 (1999).
13. Yang G. Y., Liao J., Li C., Chung J., Yurkow E. J., Ho C. T., Yang C. S., Carcinogenesis, 21, 2035-2039 (2000).
14. Dong Z., Biofactors, 12, 17-28 (2000).
15. Yang F., Oz H. S., Barve S., de Villiers W. J., McClain C. J., Varilek G. W., Mol. Pharmacol., 60, 528-533 (2001).
16. Masuda M., Suzui M., Weinstein I. B., Clin. Cancer Res., 1, 4220-4229 (2001).
17. Gupta S., Hussan T., Mukhtar H., Arch. Biochem. Biophys., 410, 177-185 (2004).
18. Lee M. J., Maliakal P., Chen L., Meng X., Bondoc F. Y., Prabhu S., Lambert G., Mohr S., Yang C. S., Cancer Epidemol. Biomarkers Prev., 11, 1025-1032 (2002).